The use of antiarrhythmic medicine in Belgium is projected to remain stable from 2024 to 2028, with a consistent value of 7.7 units per thousand persons per day. This forecasted stability indicates no year-on-year variation from 2024 onwards. In 2023, the use stood at a similar level, reflecting a steady demand for these medications over the years.
Future trends to watch for include potential advancements in alternative treatments, shifts in healthcare policies, and demographic changes such as an aging population which could influence the demand for antiarrhythmic medicines. Monitoring these factors will be crucial for anticipating any deviations from this stable trend.